Pursuant to clause 3(c)(3) of rule XIII, at the time this report was filed, the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not available.
Destruction of Hazardous Imports Act
U.S. Congress · HR2715 ·
Introduced
In Committee
Reported
Floor
Passed Chamber
Enacted
Progression
Introduced (+2 more)
Referred to the Subcommittee on Health.
Subcommittee Consideration and Mark-up… (+3 more)
Reported (Amended) by the Committee on… (+1 more)
Mr. Guthrie moved to suspend the rules… (+6 more)
2025-04-08
2026-07-21
Timing in context
Introduced (+2 more)
Referred to the Subcommittee on Health.
Subcommittee Consideration and Mark-up… (+3 more)
Reported (Amended) by the Committee on… (+8 more)
2025-01-15
2026-07-21
Primary sponsor's contributions received (same period)
Jan '25
Apr '25
Jul '25
Oct '25
Jan '26
Apr '26
Jul '26
2025-01-15
2026-07-21
Adjacency in time is shown for context; it is not evidence of cause. Funded ≠ false — see the methodology.
What the bill says
Introduced 2025-04-08. Latest action: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Summary (plain-language)
Destruction of Hazardous Imports Act This bill expands the Food and Drug Administration’s (FDA’s) authority to require the destruction of certain items that are refused import into the United States and pose a risk to public health. Under current law, imported food, drugs, medical devices, tobacco products, and cosmetics are subject to FDA review. If an imported item is deficient in a specified manner (e.g., counterfeit, misbranded, or manufactured under insanitary conditions), the item is generally refused admission to the United States. An item refused admission may generally be exported, except that the FDA may destroy a drug, medical device, or tobacco product that is valued under $2,500 without the opportunity for export. Under the bill, the FDA may order the destruction, without the opportunity for export, of any food, drug, medical device, tobacco product, or cosmetic that is refused admission if the item presents a significant public health concern. If such an order is issued, the item’s owner or consignee must destroy it within 90 days at their own cost. The bill also prohibits the unauthorized movement (e.g., export) of an item subject to a destruction order. A violator is subject to a fine, a prison term of up to one year, or both. The FDA must promulgate regulations to carry out these provisions. These regulations must provide for due process for the owner or consignee of an item subject to a destruction order, including notice and an opportunity to appear before the item is destroyed.
Sponsors
- Clay Higgins (primary)
- Gus M. Bilirakis
- Kat Cammack
- Earl L. "Buddy" Carter
- Troy A. Carter
- Rosa L. DeLauro
- Donald G. Davis
- Mike Ezell
- Cleo Fields
- Mike Haridopolos
- Jennifer A. Kiggans
- Julia Letlow
- Nancy Mace
- Gregory F. Murphy
- Barry Moore
- Troy E. Nehls
- John H. Rutherford
- W. Gregory Steube
- Randy K. Weber, Sr.
Text versions
What analysts say
Committee reports
-
H. Rept. 119-705
Pursuant to clause 3(c)(3) of rule XIII, at the time this report was filed, the cost estimate prepared by the Director of the Congressional Budget Off…
CBO cost estimate from the committee report (public domain).
What politicians say
No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.
Action History
| Date | Action |
|---|---|
| 2026-07-21 | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| 2026-07-20 | Mr. Guthrie moved to suspend the rules and pass the bill, as amended. |
| 2026-07-20 | Considered under suspension of the rules. (consideration: CR H4637-4639) |
| 2026-07-20 | DEBATE - The House proceeded with forty minutes of debate on H.R. 2715. |
| 2026-07-20 | Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4637-4638) |
| 2026-07-20 | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4637-4638) |
| 2026-07-20 | Motion to reconsider laid on the table Agreed to without objection. |
| 2026-06-18 | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-705. |
| 2026-06-18 | Placed on the Union Calendar, Calendar No. 613. |
| 2026-05-21 | Committee Consideration and Mark-up Session Held |
| 2026-05-21 | Ordered to be Reported (Amended) by the Yeas and Nays: 43 - 0. |
| 2026-05-13 | Subcommittee Consideration and Mark-up Session Held |
| 2026-05-13 | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote. |
| 2026-04-08 | Referred to the Subcommittee on Health. |
| 2025-04-08 | Introduced in House |
| 2025-04-08 | Referred to the House Committee on Energy and Commerce. |
Lobbying on this bill
Showing 5 of 5 bill mentions.
Honesty note: each filer below disclosed lobbying on this bill — that much the filing tells us. But the dollar figure is their total lobbying spend for the whole quarter across all their issues, not the amount spent on this bill, and the filing never says whether they supported or opposed it.
| Registrant (lobbying firm) | Client | Period | Reported quarterly amount | Extraction |
|---|---|---|---|---|
| PICARD KENTZ & ROWE LLP | SOUTHERN SHRIMP ALLIANCE | Q1 2026 | not reported | |
| PICARD KENTZ & ROWE LLP | SOUTHERN SHRIMP ALLIANCE | Q1 2026 | not reported | |
| PICARD KENTZ & ROWE LLP | SOUTHERN SHRIMP ALLIANCE | Q1 2026 | not reported | |
| PICARD KENTZ & ROWE LLP | SOUTHERN SHRIMP ALLIANCE | Q1 2026 | not reported | |
| PICARD KENTZ & ROWE LLP | SOUTHERN SHRIMP ALLIANCE | Q1 2026 | not reported |
Source: Senate LDA filings.